The spatial transcriptomic landscape of fibrosing ILDs [Nanostring]
RNA-seq (gene expression) · human · 179 samples
- What it is
- RNA-seq (gene expression)Gene activity measured by sequencing. The summary does not mention single-cell work, so this is most likely bulk: one average per sample, the usual starting point for comparing groups.
- Organism
- Homo sapiens (human)
- Samples
- 179 samples: 179 samples, each with a distinct title — no replicated groupsGroups are read from the sample names, not from the paper. Check the list below.
- Data you can get
- A processed table (series matrix) and supplementary files from NCBI; the raw sequencing reads from ENA. Which of these hold counts depends on the study, so check the file list.
- Paper
- Spatially resolved gene expression profiles of fibrosing interstitial lung diseasesScientific reports · 2024
Read the full summary ↓
Direct links to NCBI and ENA, no account and no request form. Pick by what you want to do: take the small processed table to look, the supplementary files to re-analyse, or the original raw data to start over.
Processed table
The series matrix: one table of values per sample as the submitters processed it. The smallest download, and it opens in Excel or R. Start here to see what the data look like.
Supplementary files
The count tables and other files the authors uploaded. Take only the samples you need, or the whole study as GSE255174_RAW.tar (it can run to tens of gigabytes).
Raw sequencing reads
The original FASTQ files, straight from the sequencer, held at ENA. Large, and you align them yourself, so only choose this if you need to re-process the study from scratch.
What the files usually look like: For RNA-seq the counts are usually a table among the supplementary files (look for 'counts', 'expression', 'FPKM' or 'TPM' in the file name). The series matrix of a sequencing study is sometimes nearly empty.
Also filed as BioProject PRJNA1073896 and SRA study SRP488470. Searching any of these in the dataset finder brings you back here.
Any grouping that defines a comparison lives in the sample characteristics, which GEO records separately from the titles.
How we read this: Read from 179 sample titles: 179 distinct titles with little repetition. These groups are guessed from the sample names, not taken from the paper, so check them against the sample list below before relying on them.
- GSM8065232 UIP-A10 | 001 | Full ROI
- GSM8065233 UIP-A10 | 002 | Full ROI
- GSM8065234 UIP-A10 | 003 | Full ROI
- GSM8065235 UIP-A10 | 004 | Full ROI
- GSM8065236 UIP-A10 | 005 | Full ROI
- GSM8065237 UIP-A10 | 006 | Full ROI
- GSM8065238 UIP-A10 | 007 | Full ROI
- GSM8065239 UIP-A10 | 008 | Full ROI
- GSM8065240 UIP-A10 | 009 | Full ROI
- GSM8065241 UIP-A10 | 010 | Full ROI
- GSM8065242 UIP-A10 | 011 | Full ROI
- GSM8065243 UIP-A10 | 012 | Full ROI
- GSM8065244 Unclassifiable-A5 | 001 | Full ROI
- GSM8065245 Unclassifiable-A5 | 003 | Full ROI
- GSM8065246 Unclassifiable-A5 | 004 | Full ROI
- GSM8065247 Unclassifiable-A5 | 005 | Full ROI
- GSM8065248 Unclassifiable-A5 | 006 | Full ROI
- GSM8065249 Unclassifiable-A5 | 007 | Full ROI
- GSM8065250 Unclassifiable-A5 | 008 | Full ROI
- GSM8065251 Unclassifiable-A5 | 009 | Full ROI
- GSM8065252 Unclassifiable-A5 | 010 | Full ROI
- GSM8065253 Unclassifiable-A5 | 011 | Full ROI
- GSM8065254 Unclassifiable-A5 | 013 | Full ROI
- GSM8065255 CHP-A3 | 001 | Full ROI
- GSM8065256 CHP-A3 | 002 | Full ROI
- GSM8065257 CHP-A3 | 003 | Full ROI
- GSM8065258 CHP-A3 | 004 | Full ROI
- GSM8065259 CHP-A3 | 005 | Full ROI
- GSM8065260 CHP-A3 | 006 | Full ROI
- GSM8065261 CHP-A3 | 007 | Full ROI
- GSM8065262 CHP-A3 | 008 | Full ROI
- GSM8065263 CHP-A3 | 009 | Full ROI
- GSM8065264 CHP-A3 | 010 | Full ROI
- GSM8065265 CHP-A3 | 011 | Full ROI
- GSM8065266 CHP-A3 | 012 | Full ROI
- GSM8065267 NSIP-B1 | 001 | Full ROI
- GSM8065268 NSIP-B1 | 002 | Full ROI
- GSM8065269 NSIP-B1 | 003 | Full ROI
- GSM8065270 NSIP-B1 | 004 | Full ROI
- GSM8065271 NSIP-B1 | 005 | Full ROI
+ 139 more — browse all 179 samples with per-sample file links →
- GSE235714 Immune-Epithelial Interactions and Tissue Remodeling in the Inflammatory Respiratory Nasal Tract [NanoString GeoMx spatial transcriptomics] 40 samples shares nanostring, spatial
- GSE264624 An integrated single-nucleus and spatial transcriptomics atlas reveals the molecular landscape of the human hippocampus [snRNA-seq] 26 samples shares spatial
- GSE271676 Spatial Transcriptional Landscape of Human Heart Failure 178 samples shares spatial
- GSE283522 The spatially informed mFISHseq assay resolves biomarker discordance and predicts treatment response in breast cancer 1254 samples shares spatial
- GSE271689 Enhancing Immunotherapy Outcomes: Spatial Multi-Omics Predictive Models for Non-Small Cell Lung Cancer 586 samples shares spatial
- GSE328930 The DUTRENEO trial: bulk prospective biomarker-guided therapy selection and spatial transcriptomic dissection of immunotherapy response in muscle-invasive bladder cancer 66 samples shares spatial
- GSE253462 The spatial landscape of glial pathology and T-cell response in Parkinson’s disease substantia nigra [snRNAseq] 41 samples shares spatial
- GSE339456 Integrated bulk and spatial transcriptomic analysis identifies progression-associated molecular signatures in biopsy-proven hypertensive nephropathy [RNA-seq] 35 samples shares spatial
Metadata from NCBI GEO, cached and refreshed periodically — the NCBI page above is authoritative. Downloads link straight to NCBI/ENA; nothing is proxied through BioTransfer.